Nitrendipine 10 mg | >98%
StressMarq Biosciences
Nitrendipine
Search Results
(-)-Indolactam V 5mg | ≥98%
CSNpharm
(-)-Indolactam V is a protein kinase C activator, which strongly directs human ES cell-derived definitive endoderm into pancreatic endoderm.
More Information Supplier Page(-)-Indolactam V 1g | 98%
BLD Pharmatech Ltd.
(-)-Indolactam V 5 mg | Purity Not Available
TargetMol
(-)-Indolactam V is a PKC activator (Kis: 3.36 nM, 1.03 μM for η-CRD2 , γ-CRD2). (-)-Indolactam V also has the Kds are 5.5 nM (η-C1B), 7.7 nM (ε-C1B), 8.3 nM (δ-C1B), 18.9 nM (β-C1A-long), 20.8 nM (α-C1A-long), 137 nM (β-C1B), 138 nM (γ-C1A), 213 nM (γ-C1B). It has antitumor activity.
More Information Supplier Page(-)-Indolactam V
(-)-Indolactam V 50 mg | Purity Not Available
TargetMol
(-)-Indolactam V is a PKC activator (Kis: 3.36 nM, 1.03 μM for η-CRD2 , γ-CRD2). (-)-Indolactam V also has the Kds are 5.5 nM (η-C1B), 7.7 nM (ε-C1B), 8.3 nM (δ-C1B), 18.9 nM (β-C1A-long), 20.8 nM (α-C1A-long), 137 nM (β-C1B), 138 nM (γ-C1A), 213 nM (γ-C1B). It has antitumor activity.
More Information Supplier Page(-)-Indolactam V
(-)-Indolactam V 100 mg | Purity Not Available
TargetMol
(-)-Indolactam V is a PKC activator (Kis: 3.36 nM, 1.03 μM for η-CRD2 , γ-CRD2). (-)-Indolactam V also has the Kds are 5.5 nM (η-C1B), 7.7 nM (ε-C1B), 8.3 nM (δ-C1B), 18.9 nM (β-C1A-long), 20.8 nM (α-C1A-long), 137 nM (β-C1B), 138 nM (γ-C1A), 213 nM (γ-C1B). It has antitumor activity.
More Information Supplier Page(-)-Indolactam V
(-)-Inosine 500 g | >98%
Clearsynth
Has neuroprotective properties improving axonal wiring. Has been used to treat stroke patients to restore neural function.
More Information Supplier Page(-)-Inpea HCl 100 mg | Purity Not Available
TargetMol
(-)-Inpea HCl
(-)-Inpea HCl 500 mg | Purity Not Available
TargetMol
(-)-Inpea HCl
(-)-Integerrimine 1 mL | Purity Not Available
TargetMol
Prenatal exposure to Integerrimine N-oxide induces maternal toxicity, impairment of maternal care and delayed in physical and behavioral development of the offspring. Doses of Integerrimine N-oxide here employed did not produce marked immunotoxic effects.
More Information Supplier Page(-)-Integerrimine
(-)-Integerrimine 5 mg | Purity Not Available
TargetMol
Prenatal exposure to Integerrimine N-oxide induces maternal toxicity, impairment of maternal care and delayed in physical and behavioral development of the offspring. Doses of Integerrimine N-oxide here employed did not produce marked immunotoxic effects.
More Information Supplier Page(-)-Integerrimine
